相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The utility of proteomics in gynecologic cancers
Toon Van Gorp et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2011)
The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer
Dirk O. Bauerschlag et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Proteomics and ovarian cancer: Integrating proteomics information into clinical care
John L. Hays et al.
JOURNAL OF PROTEOMICS (2010)
Targeted Epigenetic Therapies: The Next Frontier?
Rabiya S. Tuma
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Doctor, Should I Get This New Ovarian Cancer Test-OVA1?
Carolyn Y. Muller
OBSTETRICS AND GYNECOLOGY (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Validation of serum biomarkers for detection of early-stage ovarian cancer
Vladimir Nosov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
PROSTASIN, A POTENTIAL TUMOR MARKER IN OVARIAN CANCER- A PILOT STUDY
Fernanda Pires Costa et al.
CLINICS (2009)
Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma
Anatoliy Melnikov et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
Suraj D. Amonkar et al.
PLOS ONE (2009)
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
Digant Gupta et al.
JOURNAL OF OVARIAN RESEARCH (2009)
Issues in Imaging Malignant Neoplasms of the Female Reproductive System
Nagaraj-Setty Holalkere et al.
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2009)
Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection
Yan-jun Hong et al.
ACTA PHARMACOLOGICA SINICA (2008)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
Proteomic studies of early-stage and advanced ovarian cancer patients
Jing Wang et al.
GYNECOLOGIC ONCOLOGY (2008)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective
E. R. Woodward et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression
Iris Simon et al.
GYNECOLOGIC ONCOLOGY (2007)
Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer
Iris Simon et al.
GYNECOLOGIC ONCOLOGY (2007)
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples
Mary F. Lopez et al.
CLINICAL CHEMISTRY (2007)
Ovarian cancer screening with annual transvaginal sonography - Findings of 25,000 women screened
John R. van Nagell et al.
CANCER (2007)
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers
Li Hong Bao et al.
JOURNAL OF BIOMEDICAL SCIENCE (2007)
Early detection of ovarian cancer
Donna Badgwell et al.
DISEASE MARKERS (2007)
Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer
Changqing Zhao et al.
NEOPLASIA (2007)
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population
Lee E. Moore et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer
Anna E. Lokshin et al.
GYNECOLOGIC ONCOLOGY (2006)
Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer
Mitsuhiro Nakae et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2006)
Prognostic DNA methylation biomarkers in ovarian cancer
SH Wei et al.
CLINICAL CANCER RESEARCH (2006)
Bead-based ELISA for validation of ovarian cancer early detection markers
N Scholler et al.
CLINICAL CANCER RESEARCH (2006)
B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer
I Simon et al.
CANCER RESEARCH (2006)
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine
B Ye et al.
CLINICAL CANCER RESEARCH (2006)
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer
R Hassan et al.
CLINICAL CANCER RESEARCH (2006)
Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer
A Wiley et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Identification of genes associated with ovarian cancer metastasis using microarray expression analysis
J. M. Lancaster et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer
RI Olivier et al.
GYNECOLOGIC ONCOLOGY (2006)
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
N Ahmed et al.
PROTEOMICS (2005)
Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System
D Stirling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors
CB Wilcox et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy
G Strathdee et al.
GYNECOLOGIC ONCOLOGY (2005)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation
S Salceda et al.
EXPERIMENTAL CELL RESEARCH (2005)
Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer
E Gorelik et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer
M Kaneuchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Decreased expression of 14-3-3σ is associated with advanced disease in human epithelial ovarian cancer:: Its correlation with aberrant DNA methylation
J Akahira et al.
CLINICAL CANCER RESEARCH (2004)
Haptoglobin polymorphism in breast cancer patients form Jordan
SM Awadallah et al.
CLINICA CHIMICA ACTA (2004)
DNA hypomethylation and ovarian cancer biology
M Widschwendter et al.
CANCER RESEARCH (2004)
Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival
DG Rosen et al.
CLINICAL CANCER RESEARCH (2004)
Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer
KA Brakora et al.
GYNECOLOGIC ONCOLOGY (2004)
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
MW McIntosh et al.
GYNECOLOGIC ONCOLOGY (2004)
Characterization of the low molecular weight human serum proteome
RS Tirumalai et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer
GC Sellar et al.
NATURE GENETICS (2003)
Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas
JH Yoon et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Prostasin, a potential serum marker for ovarian cancer: Identification through microarray technology
SC Mok et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Methylation matters
JF Costello et al.
JOURNAL OF MEDICAL GENETICS (2001)
Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes
G Strathdee et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
